BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 61857)

  • 1. [Steroid metabolism in primates. XVIII. Return to higher levels of 17-ketosteroid excretion in urine after ending a long-term treatment with mestranol/chlormadinone acetate in the baboon].
    Gontscharow NP; Woronzow WI; Schön R; Hobe G; Schubert K
    Endokrinologie; 1976 Jul; 67(3):362-4. PubMed ID: 61857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Steroid metabolism in primates. XV. Excretion of C19 and C21 steroids in the urine of baboons (Papio hamadryas) after long-term treatment with a combination of mestranol-chlormadinone acetate].
    Gontscharow NP; Woronzow WI; Rutschizkaja SJ; Schön R; Schubert K
    Endokrinologie; 1974 Nov; 64(1):74-80. PubMed ID: 4143128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Steroid metabolism in primates. XIV. Influence of long-term ovosiston therapy on the secretion of adrenal vein blood steroids in Papio hamadryas].
    Gontscharow NP; Komor A; Wehrberger K; Schön R; Schubert K
    Endokrinologie; 1972 Nov; 60(3):379-81. PubMed ID: 4121482
    [No Abstract]   [Full Text] [Related]  

  • 4. Rate of secretion of corticosteroids in hamadryas baboons under normal conditions and following lengthy administration of chlormadinone acetate and mestranol.
    Goncharov NP
    Acta Endocrinol Suppl (Copenh); 1972; 166():428-32. PubMed ID: 4116113
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential mestranol-chlormadinone acetate as an oral contraceptive.
    Tyler ET
    Obstet Gynecol; 1966 Dec; 28(6):787-92. PubMed ID: 4162518
    [No Abstract]   [Full Text] [Related]  

  • 6. ["1st experiences with Ovosiston in a new dosage--a comparative study of oral contraception with 'old' and 'new' Ovosiston". "Experiences with Ovosiston in contraception. II. " Reply to the viewpoint of D. Kühne].
    Zwahr C
    Dtsch Gesundheitsw; 1970 Nov; 25(47):2247-50. PubMed ID: 4099776
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of mestranol and chlormadinone acetate on urinary excretion of FSH and LH.
    Stevens VC; Goldzieher JW; Vorys N
    Am J Obstet Gynecol; 1968 Sep; 102(1):95-105. PubMed ID: 4175034
    [No Abstract]   [Full Text] [Related]  

  • 8. [Endometrium during administration of sequence-ovosiston (report on 3 variants of sequential therapy)].
    Böhm W; Hempel E; Klinger G; Carol W
    Zentralbl Gynakol; 1972 Dec; 94(52):1816-20. PubMed ID: 4119792
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inhibitors of human ovulation. General principles and accumulated experiences with sequential therapy based on mestranol and chlormadinone acetate].
    Zorrilla E
    Prensa Med Mex; 1968; 33(11):453-64. PubMed ID: 4105432
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with the different dosage of Ovosiston preparations in the framework of marital and sexual counseling. Individual therapy with oral contraceptives].
    Ebeling K; Kühndel K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(2):61-4. PubMed ID: 4106277
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term effects of the estrogen-gestagen combination preparation Ovosiston on glucose level in the insulin tolerance test].
    Goretzlehner G; Rudolf K; Töwe J
    Zentralbl Gynakol; 1974 Oct; 96(40):1249-53. PubMed ID: 4141548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified sequential oral contraception employing mestranol with chlormadinone.
    Tyler ET; Matsner EM; Gotlib M
    Obstet Gynecol; 1969 Dec; 34(6):820-4. PubMed ID: 4189147
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with different doses of Ovosiston preparations within the scope of marital and sexual counseling. Individual therapy with oral contraceptives].
    Ebeling K; Kühndel K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(1):31-4. PubMed ID: 4106517
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experiences with Ovosiston in a new dosage form].
    Zwahr C
    Dtsch Gesundheitsw; 1970 Apr; 25(14):635-9. PubMed ID: 4098545
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the contraceptive effects of periodic administration of mestranol 0.08mg and chlormadinone acetate 2mg (S-3850 tablets)].
    Kobayashi T; Amemori Y; Watanabe T; Ichikawa T
    Horumon To Rinsho; 1968 May; 16(5):403-9. PubMed ID: 4177677
    [No Abstract]   [Full Text] [Related]  

  • 16. [Our experiences in the inhibition of undesired lactation using Ovosiston].
    Kosowski I; Iliew D
    Zentralbl Gynakol; 1972 Aug; 94(34):1134-6. PubMed ID: 4116879
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with Ovosiston in marital and sexual counseling in a district hospital in the period Jan. 1, 1967-Dec. 31, 1968].
    Keil G
    Z Arztl Fortbild (Jena); 1970 May; 64(10):500-1. PubMed ID: 4106558
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical application of the mixture of mestranol and chlormadinone for functional anomaly of the ovary].
    Kobayshi T; Amenomori Y; Nagai N; Egusa M; Ichikawa T
    Saishin Igaku; 1966 Sep; 21(9):2089-94. PubMed ID: 4166819
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the two-phase treatment with mestranol-chlormadinone acetate in dysfunctional hemorrhages, functional sterility and dys-or hypogonadotropic amenorrheas].
    Göretzlehner G
    Dtsch Gesundheitsw; 1967 Jun; 22(24):1124-6. PubMed ID: 4176451
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sequenz-Ovosiston as a contraceptive agent].
    Zwahr C
    Zentralbl Gynakol; 1972 Dec; 94(49):1722-5. PubMed ID: 4119508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.